The Australian company Mesoblast begins clinical trials of angiogenesis stimulation technology in the heart by introducing "adult" bone marrow stem cells
- 作者: Likhachev D.
- 期: 卷 1, 编号 2 (2006)
- 页面: 27-27
- 栏目: Cell technology
- ##submission.dateSubmitted##: 10.02.2023
- ##submission.dateAccepted##: 10.02.2023
- ##submission.datePublished##: 15.02.2006
- URL: https://genescells.ru/2313-1829/article/view/217684
- DOI: https://doi.org/10.23868/gc217684
- ID: 217684
如何引用文章
全文:
![受限制的访问](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
参考
补充文件
![](/img/style/loading.gif)